Last 12 months
Inside the activity.
1 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 1 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 02, 2026 Filed Mar 3, 2026 21:58 UTC |
Cozad StacyEVP & Chief Legal Officer
|
GrantNon-Qualified Stock Options (Right to Buy) · Derivative | 5,570 | $128.98 Strike: $128.98 | $718,418.60 |
DisclosureSEC source: 0001524472-26-000038 · form4.xml · derivative · entry 2 Cozad Stacy · CIK 0001663264 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,570 Underlying: Common Stock · 5,570 shares Expires 2036-03-02 F2 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:58 UTC |
Cozad StacyEVP & Chief Legal Officer
|
GrantCommon Stock | 1,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001524472-26-000038 · form4.xml · nonDerivative · entry 1 Cozad Stacy · CIK 0001663264 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,303 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:56 UTC |
McGann Michael J.EVP & President, MCS
|
GrantNon-Qualified Stock Options (Right to Buy) · Derivative | 5,739 | $128.98 Strike: $128.98 | $740,216.22 |
DisclosureSEC source: 0001524472-26-000037 · form4.xml · derivative · entry 9 McGann Michael J. · CIK 0001962070 · EVP & President, MCS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,739 Underlying: Common Stock · 5,739 shares Expires 2036-03-02 F10 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:56 UTC |
McGann Michael J.EVP & President, MCS
|
Tax withholdingCommon Stock | 510 | $128.98 | $65,779.80 |
DisclosureSEC source: 0001524472-26-000037 · form4.xml · nonDerivative · entry 8 McGann Michael J. · CIK 0001962070 · EVP & President, MCS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,225 F9 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (269) and March 1, 2024 (241) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:56 UTC |
McGann Michael J.EVP & President, MCS
|
Tax withholdingCommon Stock | 213 | $128.98 | $27,472.74 |
DisclosureSEC source: 0001524472-26-000037 · form4.xml · nonDerivative · entry 7 McGann Michael J. · CIK 0001962070 · EVP & President, MCS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,735 F8 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:56 UTC |
McGann Michael J.EVP & President, MCS
|
Tax withholdingCommon Stock | 2,073 | $128.98 | $267,375.54 |
DisclosureSEC source: 0001524472-26-000037 · form4.xml · nonDerivative · entry 6 McGann Michael J. · CIK 0001962070 · EVP & President, MCS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,948 F7 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:56 UTC |
McGann Michael J.EVP & President, MCS
|
GrantCommon Stock | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001524472-26-000037 · form4.xml · nonDerivative · entry 5 McGann Michael J. · CIK 0001962070 · EVP & President, MCS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,021 F6 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:44 UTC |
Yarkadas HayatiEVP & President, WI
|
GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 8,102 | $128.98 Strike: $128.98 | $1,044,995.96 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · derivative · entry 9 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,102 Underlying: Common Stock · 8,102 shares Expires 2036-03-02 F10 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:44 UTC |
Yarkadas HayatiEVP & President, WI
|
Tax withholdingCommon Stock | 117 | $128.98 | $15,090.66 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 8 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,581 F9 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (75) and March 1, 2024 (42) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:44 UTC |
Yarkadas HayatiEVP & President, WI
|
Tax withholdingCommon Stock | 94 | $128.98 | $12,124.12 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 7 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,698 F8 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:44 UTC |
Yarkadas HayatiEVP & President, WI
|
Tax withholdingCommon Stock | 565 | $128.98 | $72,873.70 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 6 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,792 F7 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:44 UTC |
Yarkadas HayatiEVP & President, WI
|
GrantCommon Stock | 2,274 | $0.00 | $0.00 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 5 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,357 F6 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:52 UTC |
Aulick RodneyEVP & President, WSS
|
GrantNon-Qualified Stock Options (Right to Buy) · Derivative | 5,739 | $128.98 Strike: $128.98 | $740,216.22 |
DisclosureSEC source: 0001524472-26-000035 · form4.xml · derivative · entry 3 Aulick Rodney · CIK 0001720147 · EVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,739 Underlying: Common Stock · 5,739 shares Expires 2036-03-02 F4 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:52 UTC |
Aulick RodneyEVP & President, WSS
|
Tax withholdingCommon Stock | 238 | $128.98 | $30,697.24 |
DisclosureSEC source: 0001524472-26-000035 · form4.xml · nonDerivative · entry 2 Aulick Rodney · CIK 0001720147 · EVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,917 F3 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2024 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:52 UTC |
Aulick RodneyEVP & President, WSS
|
GrantCommon Stock | 1,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001524472-26-000035 · form4.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · EVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,155 F1 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:01 UTC |
McShane Geri-MichelleSVP, CAO
|
GrantNon-Qualified Stock Options (Right to Buy) · Derivative | 2,194 | $128.98 Strike: $128.98 | $282,982.12 |
DisclosureSEC source: 0001524472-26-000032 · form4.xml · derivative · entry 9 McShane Geri-Michelle · CIK 0001769064 · SVP, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,194 Underlying: Common Stock · 2,194 shares Expires 2036-03-02 F9 · derivative.exercise_date: Reflects an award of non-qualified stock options pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one-third increments on March 1, 2027, March 1, 2028 and March 1, 2029. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:01 UTC |
McShane Geri-MichelleSVP, CAO
|
Tax withholdingCommon Stock | 150 | $128.98 | $19,347.00 |
DisclosureSEC source: 0001524472-26-000032 · form4.xml · nonDerivative · entry 8 McShane Geri-Michelle · CIK 0001769064 · SVP, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,791 F8 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on March 1, 2023 (82) and March 1, 2024 (68) under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:01 UTC |
McShane Geri-MichelleSVP, CAO
|
Tax withholdingCommon Stock | 188 | $128.98 | $24,248.24 |
DisclosureSEC source: 0001524472-26-000032 · form4.xml · nonDerivative · entry 7 McShane Geri-Michelle · CIK 0001769064 · SVP, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,941 F7 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of ESG performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24, 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:01 UTC |
McShane Geri-MichelleSVP, CAO
|
Tax withholdingCommon Stock | 654 | $128.98 | $84,352.92 |
DisclosureSEC source: 0001524472-26-000032 · form4.xml · nonDerivative · entry 6 McShane Geri-Michelle · CIK 0001769064 · SVP, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,129 F6 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February, 24 2016). Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 21:01 UTC |
McShane Geri-MichelleSVP, CAO
|
GrantCommon Stock | 616 | $0.00 | $0.00 |
DisclosureSEC source: 0001524472-26-000032 · form4.xml · nonDerivative · entry 5 McShane Geri-Michelle · CIK 0001769064 · SVP, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,783 F5 · shares: Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in one third increments on March 1, 2027, March 1, 2028 and March 1, 2029. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:02 UTC |
Pine Matthew FrancisDirector · Pres. & CEO
|
GrantCommon Stock | 2,152 | $128.98 | $277,564.96 |
DisclosureSEC source: 0001524472-26-000040 · form4.xml · nonDerivative · entry 4 Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,936 F5 · shares: Reflects the acquisition of 2,152 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:02 UTC |
Pine Matthew FrancisDirector · Pres. & CEO
|
GrantCommon Stock | 2,943 | $128.98 | $379,588.14 |
DisclosureSEC source: 0001524472-26-000040 · form4.xml · nonDerivative · entry 3 Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,784 F4 · shares: Reflects the acquisition of 2,943 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:02 UTC |
Pine Matthew FrancisDirector · Pres. & CEO
|
GrantCommon Stock | 4,328 | $128.98 | $558,225.44 |
DisclosureSEC source: 0001524472-26-000040 · form4.xml · nonDerivative · entry 2 Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,841 F3 · shares: Reflects the acquisition of 4,328 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 17:02 UTC |
Pine Matthew FrancisDirector · Pres. & CEO
|
GrantCommon Stock | 5,243 | $128.98 | $676,242.14 |
DisclosureSEC source: 0001524472-26-000040 · form4.xml · nonDerivative · entry 1 Pine Matthew Francis · CIK 0001807057 · Director · Pres. & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,513 F1 · shares: Reflects the acquisition of 5,243 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:53 UTC |
Grogan William KEVP & Chief Financial Officer
|
GrantCommon Stock | 3,117 | $128.98 | $402,030.66 |
DisclosureSEC source: 0001524472-26-000036 · form4.xml · nonDerivative · entry 3 Grogan William K · CIK 0001694002 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,501 F4 · shares: Reflects the acquisition of 3,117 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:53 UTC |
Grogan William KEVP & Chief Financial Officer
|
GrantCommon Stock | 4,583 | $128.98 | $591,115.34 |
DisclosureSEC source: 0001524472-26-000036 · form4.xml · nonDerivative · entry 2 Grogan William K · CIK 0001694002 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,384 F3 · shares: Reflects the acquisition of 4,583 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:53 UTC |
Grogan William KEVP & Chief Financial Officer
|
GrantCommon Stock | 5,551 | $128.98 | $715,967.98 |
DisclosureSEC source: 0001524472-26-000036 · form4.xml · nonDerivative · entry 1 Grogan William K · CIK 0001694002 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,801 F1 · shares: Reflects the acquisition of 5,551 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 16:51 UTC |
Toussaint Claudia SEVP, CPSO
|
GrantCommon Stock | 1,761 | $128.98 | $227,133.78 |
DisclosureSEC source: 0001524472-26-000034 · form4.xml · nonDerivative · entry 4 Toussaint Claudia S · CIK 0001421560 · EVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,332 F4 · shares: Reflects the acquisition of 1,761 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 16:51 UTC |
Toussaint Claudia SEVP, CPSO
|
GrantCommon Stock | 1,324 | $128.98 | $170,769.52 |
DisclosureSEC source: 0001524472-26-000034 · form4.xml · nonDerivative · entry 3 Toussaint Claudia S · CIK 0001421560 · EVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,571 F3 · shares: Reflects the acquisition of 1,324 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 16:51 UTC |
Toussaint Claudia SEVP, CPSO
|
GrantCommon Stock | 1,948 | $128.98 | $251,253.04 |
DisclosureSEC source: 0001524472-26-000034 · form4.xml · nonDerivative · entry 2 Toussaint Claudia S · CIK 0001421560 · EVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,247 F2 · shares: Reflects the acquisition of 1,948 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 16:51 UTC |
Toussaint Claudia SEVP, CPSO
|
GrantCommon Stock | 2,360 | $128.98 | $304,392.80 |
DisclosureSEC source: 0001524472-26-000034 · form4.xml · nonDerivative · entry 1 Toussaint Claudia S · CIK 0001421560 · EVP, CPSO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,299 F1 · shares: Reflects the acquisition of 2,360 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:05 UTC |
Cho AlbertEVP, Strategy
|
GrantCommon Stock | 587 | $128.98 | $75,711.26 |
DisclosureSEC source: 0001524472-26-000041 · form4.xml · nonDerivative · entry 4 Cho Albert · CIK 0002025025 · EVP, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,822 F5 · shares: Reflects the acquisition of 587 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:05 UTC |
Cho AlbertEVP, Strategy
|
GrantCommon Stock | 735 | $128.98 | $94,800.30 |
DisclosureSEC source: 0001524472-26-000041 · form4.xml · nonDerivative · entry 3 Cho Albert · CIK 0002025025 · EVP, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,235 F4 · shares: Reflects the acquisition of 735 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:05 UTC |
Cho AlbertEVP, Strategy
|
GrantCommon Stock | 1,082 | $128.98 | $139,556.36 |
DisclosureSEC source: 0001524472-26-000041 · form4.xml · nonDerivative · entry 2 Cho Albert · CIK 0002025025 · EVP, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,500 F3 · shares: Reflects the acquisition of 1,082 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 22:05 UTC |
Cho AlbertEVP, Strategy
|
GrantCommon Stock | 1,311 | $128.98 | $169,092.78 |
DisclosureSEC source: 0001524472-26-000041 · form4.xml · nonDerivative · entry 1 Cho Albert · CIK 0002025025 · EVP, Strategy 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,418 F1 · shares: Reflects the acquisition of 1,311 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:56 UTC |
McGann Michael J.EVP & President, MCS
|
GrantCommon Stock | 489 | $128.98 | $63,071.22 |
DisclosureSEC source: 0001524472-26-000037 · form4.xml · nonDerivative · entry 4 McGann Michael J. · CIK 0001962070 · EVP & President, MCS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,411 F5 · shares: Reflects the acquisition of 489 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:56 UTC |
McGann Michael J.EVP & President, MCS
|
GrantCommon Stock | 1,103 | $128.98 | $142,264.94 |
DisclosureSEC source: 0001524472-26-000037 · form4.xml · nonDerivative · entry 3 McGann Michael J. · CIK 0001962070 · EVP & President, MCS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,922 F4 · shares: Reflects the acquisition of 1,103 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:56 UTC |
McGann Michael J.EVP & President, MCS
|
GrantCommon Stock | 1,622 | $128.98 | $209,205.56 |
DisclosureSEC source: 0001524472-26-000037 · form4.xml · nonDerivative · entry 2 McGann Michael J. · CIK 0001962070 · EVP & President, MCS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,819 F3 · shares: Reflects the acquisition of 1,622 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:56 UTC |
McGann Michael J.EVP & President, MCS
|
GrantCommon Stock | 1,966 | $128.98 | $253,574.68 |
DisclosureSEC source: 0001524472-26-000037 · form4.xml · nonDerivative · entry 1 McGann Michael J. · CIK 0001962070 · EVP & President, MCS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,197 F1 · shares: Reflects the acquisition of 1,966 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:44 UTC |
Yarkadas HayatiEVP & President, WI
|
GrantCommon Stock | 1,761 | $128.98 | $227,133.78 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 4 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,083 F5 · shares: Reflects the acquisition of 1,761 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:44 UTC |
Yarkadas HayatiEVP & President, WI
|
GrantCommon Stock | 2,501 | $128.98 | $322,578.98 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 3 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,322 F4 · shares: Reflects the acquisition of 2,501 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:44 UTC |
Yarkadas HayatiEVP & President, WI
|
GrantCommon Stock | 3,679 | $128.98 | $474,517.42 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 2 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,821 F3 · shares: Reflects the acquisition of 3,679 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:44 UTC |
Yarkadas HayatiEVP & President, WI
|
GrantCommon Stock | 4,456 | $128.98 | $574,734.88 |
DisclosureSEC source: 0001524472-26-000033 · form4.xml · nonDerivative · entry 1 Yarkadas Hayati · CIK 0001657363 · EVP & President, WI 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,142 F1 · shares: Reflects the acquisition of 4,456 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:01 UTC |
McShane Geri-MichelleSVP, CAO
|
GrantCommon Stock | 489 | $128.98 | $63,071.22 |
DisclosureSEC source: 0001524472-26-000032 · form4.xml · nonDerivative · entry 4 McShane Geri-Michelle · CIK 0001769064 · SVP, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,167 F4 · shares: Reflects the acquisition of 489 shares of common stock upon vesting of performance-based stock units granted on March 1, 2021 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to ESG performance. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:01 UTC |
McShane Geri-MichelleSVP, CAO
|
GrantCommon Stock | 405 | $128.98 | $52,236.90 |
DisclosureSEC source: 0001524472-26-000032 · form4.xml · nonDerivative · entry 3 McShane Geri-Michelle · CIK 0001769064 · SVP, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,678 F3 · shares: Reflects the acquisition of 405 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Revenue. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:01 UTC |
McShane Geri-MichelleSVP, CAO
|
GrantCommon Stock | 595 | $128.98 | $76,743.10 |
DisclosureSEC source: 0001524472-26-000032 · form4.xml · nonDerivative · entry 2 McShane Geri-Michelle · CIK 0001769064 · SVP, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,273 F2 · shares: Reflects the acquisition of 595 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Adjusted EBITDA. Read SEC document |
| March 01, 2026 Filed Mar 3, 2026 21:01 UTC |
McShane Geri-MichelleSVP, CAO
|
GrantCommon Stock | 721 | $128.98 | $92,994.58 |
DisclosureSEC source: 0001524472-26-000032 · form4.xml · nonDerivative · entry 1 McShane Geri-Michelle · CIK 0001769064 · SVP, CAO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,678 F1 · shares: Reflects the acquisition of 721 shares of common stock upon vesting of performance-based stock units granted on March 1, 2023 under the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016), upon achievement of performance criteria related to Total Shareholder Return. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:15 UTC |
Aulick RodneyEVP & President, WSS
|
Tax withholdingCommon Stock | 457 | $136.18 | $62,234.26 |
DisclosureSEC source: 0001524472-26-000002 · form4.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · EVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,545 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on December 9, 2022 under the Amended and Restated Evoqua Water Technologies Corp. 2017 Equity Incentive Plan that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023 F2 · balance_after: Includes additional shares due to dividend reinvestment. Read SEC document |
| December 15, 2025 Filed Dec 15, 2025 21:25 UTC |
Aulick RodneyEVP & President, WSS
|
Tax withholdingCommon Stock | 1,840 | $138.25 | $254,380.00 |
DisclosureSEC source: 0001524472-25-000054 · form4.xml · nonDerivative · entry 1 Aulick Rodney · CIK 0001720147 · EVP & President, WSS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,826 F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on December 9, 2022 (1,840) under the Amended and Restated Evoqua Water Technologies Corp. 2017 Equity Incentive Plan that were converted to Xylem restricted stock units in connection with the Merger on May 24, 2023 Read SEC document |
| November 04, 2025 Filed Nov 5, 2025 21:16 UTC |
Harker Victoria DDirector
|
SaleCommon Stock | 1,700 | $148.14 | $251,838.00 |
DisclosureSEC source: 0001524472-25-000052 · form4.xml · nonDerivative · entry 1 Harker Victoria D · CIK 0001350579 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,875 F1 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,700 Shares were executed at a range of prices from $148.135 to $148.135. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.